Many previous studies have shown that YAP plays an important role in promoting the epithelial–mesenchymal transition (EMT), drug resistance, and metastasis in NSCLC [67,68,69,70,71,72,73,74,75,76]. This evidence concerns the gene YAP1 and non-small cell lung carcinoma.